BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 22086652)

  • 1. Computational and experimental studies of the interaction between phospho-peptides and the C-terminal domain of BRCA1.
    Anisimov VM; Ziemys A; Kizhake S; Yuan Z; Natarajan A; Cavasotto CN
    J Comput Aided Mol Des; 2011 Nov; 25(11):1071-84. PubMed ID: 22086652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphopeptide interactions with BRCA1 BRCT domains: More than just a motif.
    Wu Q; Jubb H; Blundell TL
    Prog Biophys Mol Biol; 2015 Mar; 117(2-3):143-148. PubMed ID: 25701377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Promiscuous Binding of Phosphor Ligands to Breast-Cancer-Gene 1 (BRCA1) C-Terminal (BRCT): Molecular Dynamics, Free Energy, Entropy and Inhibitor Design.
    You W; Huang YM; Kizhake S; Natarajan A; Chang CE
    PLoS Comput Biol; 2016 Aug; 12(8):e1005057. PubMed ID: 27560145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural characterization of BRCT-tetrapeptide binding interactions.
    Joseph PR; Yuan Z; Kumar EA; Lokesh GL; Kizhake S; Rajarathnam K; Natarajan A
    Biochem Biophys Res Commun; 2010 Mar; 393(2):207-10. PubMed ID: 20122900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for the BRCA1 BRCT interaction with the proteins ATRIP and BAAT1.
    Liu X; Ladias JA
    Biochemistry; 2013 Oct; 52(43):7618-27. PubMed ID: 24073851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1.
    Williams RS; Lee MS; Hau DD; Glover JN
    Nat Struct Mol Biol; 2004 Jun; 11(6):519-25. PubMed ID: 15133503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains.
    Rodriguez M; Yu X; Chen J; Songyang Z
    J Biol Chem; 2003 Dec; 278(52):52914-8. PubMed ID: 14578343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRCT repeats as phosphopeptide-binding modules involved in protein targeting.
    Manke IA; Lowery DM; Nguyen A; Yaffe MB
    Science; 2003 Oct; 302(5645):636-9. PubMed ID: 14576432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of BRCT domains of BRCA1 and 53BP1: a biophysical analysis.
    Ekblad CM; Friedler A; Veprintsev D; Weinberg RL; Itzhaki LS
    Protein Sci; 2004 Mar; 13(3):617-25. PubMed ID: 14978302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis of BACH1 phosphopeptide recognition by BRCA1 tandem BRCT domains.
    Botuyan MV; Nominé Y; Yu X; Juranic N; Macura S; Chen J; Mer G
    Structure; 2004 Jul; 12(7):1137-46. PubMed ID: 15242590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The BRCT domain is a phospho-protein binding domain.
    Yu X; Chini CC; He M; Mer G; Chen J
    Science; 2003 Oct; 302(5645):639-42. PubMed ID: 14576433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic analysis of interaction of BRCA1 tandem breast cancer c-terminal domains with phosphorylated peptides reveals two binding conformations.
    Nominé Y; Botuyan MV; Bajzer Z; Owen WG; Caride AJ; Wasielewski E; Mer G
    Biochemistry; 2008 Sep; 47(37):9866-79. PubMed ID: 18717574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the structures and peptide binding specificities of the BRCT domains of MDC1 and BRCA1.
    Campbell SJ; Edwards RA; Glover JN
    Structure; 2010 Feb; 18(2):167-76. PubMed ID: 20159462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRCT domain interactions in the heterodimeric DNA repair protein XRCC1-DNA ligase III.
    Dulic A; Bates PA; Zhang X; Martin SR; Freemont PS; Lindahl T; Barnes DE
    Biochemistry; 2001 May; 40(20):5906-13. PubMed ID: 11352725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of cancer-linked BRCA1-BRCT missense variants and their interaction with phosphoprotein targets.
    Drikos I; Nounesis G; Vorgias CE
    Proteins; 2009 Nov; 77(2):464-76. PubMed ID: 19452558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and mechanism of BRCA1 BRCT domain recognition of phosphorylated BACH1 with implications for cancer.
    Clapperton JA; Manke IA; Lowery DM; Ho T; Haire LF; Yaffe MB; Smerdon SJ
    Nat Struct Mol Biol; 2004 Jun; 11(6):512-8. PubMed ID: 15133502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRCT domains: phosphopeptide binding and signaling modules.
    Rodriguez MC; Songyang Z
    Front Biosci; 2008 May; 13():5905-15. PubMed ID: 18508631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMR mapping of PCNA interaction with translesion synthesis DNA polymerase Rev1 mediated by Rev1-BRCT domain.
    Pustovalova Y; Maciejewski MW; Korzhnev DM
    J Mol Biol; 2013 Sep; 425(17):3091-105. PubMed ID: 23747975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Similarity trap" in protein-protein interactions could be carcinogenic: simulations of p53 core domain complexed with 53BP1 and BRCA1 BRCT domains.
    Liu J; Pan Y; Ma B; Nussinov R
    Structure; 2006 Dec; 14(12):1811-21. PubMed ID: 17161371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of BRCA1 BRCT domain missense substitutions on phosphopeptide recognition.
    Coquelle N; Green R; Glover JN
    Biochemistry; 2011 May; 50(21):4579-89. PubMed ID: 21473589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.